Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteria

Accurate appraisal of treatment response in metastatic castrate-resistant prostate cancer (mCRPC) is challenging in view of remarkable tumor heterogeneity and the available choices among many established and novel therapeutic approaches. The purpose of this single-center prospective study was to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Velez, Erik M., Desai, Bhushan, Ji, Lingyun, Quinn, David I., Colletti, Patrick M., Jadvar, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053201/
https://www.ncbi.nlm.nih.gov/pubmed/32194866
http://dx.doi.org/10.7150/thno.39838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053201/
https://www.ncbi.nlm.nih.gov/pubmed/32194866
http://dx.doi.org/10.7150/thno.39838

Ejemplares similares